What Is Low-Dose Naltrexone?

Low-dose naltrexone (LDN) refers to naltrexone used at doses of 1-5mg, much lower than the standard 50mg dose used for addiction. At these low doses, it's thought to have different effects that may help with pain and inflammation. It's an off-label use gaining interest for chronic pain conditions.1

How It May Work2

  • Modulates the immune system
  • Reduces glial cell activation in nervous system
  • May decrease inflammation
  • Temporarily blocks opioid receptors
  • May increase endorphin production (rebound effect)

Conditions Being Studied

  • Fibromyalgia (most research)
  • Chronic fatigue syndrome
  • Multiple sclerosis
  • Crohn's disease
  • Complex regional pain syndrome
  • Rheumatoid arthritis

Evidence3

  • Small studies show promise for fibromyalgia
  • Some benefit seen in autoimmune conditions
  • Research is still limited
  • Large clinical trials needed
  • Not FDA-approved for pain

Dosing

  • Typically 1.5-4.5mg daily
  • Usually taken at bedtime
  • Often started low and increased gradually
  • Requires compounding pharmacy
  • Regular naltrexone tablets are 50mg

Side Effects

  • Generally well-tolerated
  • Vivid dreams (common)
  • Sleep disturbances (usually temporary)
  • Nausea
  • Headache
  • Most side effects diminish over time

Important Considerations

  • Cannot take with opioid medications
  • Must stop opioids before starting LDN
  • Not covered by most insurance
  • Requires compounding (cost varies)
  • Many doctors unfamiliar with LDN

Finding LDN

  • Requires prescription
  • Need compounding pharmacy
  • Some integrative medicine doctors prescribe
  • Ask if your doctor is familiar with LDN research

References

  1. Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459.
  2. Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009;10(4):663-672.
  3. Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders. Pharmacotherapy. 2018;38(3):382-389.